{"id":"https://openalex.org/W4387728840","doi":"https://doi.org/10.4103//ant.33-1_111_0067","title":"Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats","display_name":"Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4387728840","doi":"https://doi.org/10.4103//ant.33-1_111_0067","pmid":"https://pubmed.ncbi.nlm.nih.gov/37848239"},"language":"en","primary_location":{"id":"doi:10.4103//ant.33-1_111_0067","doi":"https://doi.org/10.4103//ant.33-1_111_0067","is_oa":true,"landing_page_url":"https://doi.org/10.4103//ant.33-1_111_0067","pdf_url":null,"source":{"id":"https://openalex.org/S4306500427","display_name":"Acta Neurologica Taiwanica","issn_l":"1028-768X","issn":["1028-768X","3050-9173"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Taiwanica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.4103//ant.33-1_111_0067","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021852245","display_name":"\u00d6zlem Kara","orcid":"https://orcid.org/0000-0002-2084-8290","observed_orcids":["https://orcid.org/0000-0002-2084-8290"]},"institutions":[{"id":"https://openalex.org/I204483917","display_name":"Ahi Evran University","ror":"https://ror.org/05rrfpt58","country_code":"TR","type":"education","lineage":["https://openalex.org/I204483917"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Ozlem Kara","raw_affiliation_strings":["From the Kirsehir Ahi Evran University School of Medicine, Department of Histology and Embryology, Kirsehir, Turkey"],"raw_orcid":"https://orcid.org/0000-0002-2084-8290","affiliations":[{"raw_affiliation_string":"From the Kirsehir Ahi Evran University School of Medicine, Department of Histology and Embryology, Kirsehir, Turkey","institution_ids":["https://openalex.org/I204483917"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010904214","display_name":"Asuman Kilit\u00e7i","orcid":"https://orcid.org/0000-0002-5489-2222","observed_orcids":["https://orcid.org/0000-0002-5489-2222"]},"institutions":[{"id":"https://openalex.org/I54001450","display_name":"D\u00fczce \u00dcniversitesi","ror":"https://ror.org/04175wc52","country_code":"TR","type":"education","lineage":["https://openalex.org/I54001450"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Asuman Kilitci","raw_affiliation_strings":["From the Duzce University School of Medicine, Department of Pathology, Duzce, Turkey"],"raw_orcid":"https://orcid.org/0000-0002-5489-2222","affiliations":[{"raw_affiliation_string":"From the Duzce University School of Medicine, Department of Pathology, Duzce, Turkey","institution_ids":["https://openalex.org/I54001450"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021852245"],"corresponding_institution_ids":["https://openalex.org/I204483917"],"apc_list":null,"apc_paid":null,"fwci":0.4789,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.52783619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"33","issue":"1","first_page":"9","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13077","display_name":"Cancer-related cognitive impairment studies","score":0.02850000001490116,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/edaravone","display_name":"edaravone","score":1.0},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cisplatin-neurotoxicity","display_name":"cisplatin neurotoxicity","score":0.9340000152587891},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8130000233650208},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8820000290870667},{"id":"https://openalex.org/keywords/malondialdehyde","display_name":"malondialdehyde","score":0.8519999980926514},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":1.0},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8579999804496765},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.996999979019165},{"id":"https://openalex.org/keywords/glial-fibrillary-acidic-protein","display_name":"glial fibrillary acidic protein","score":0.9549999833106995},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.8579999804496765},{"id":"https://openalex.org/keywords/brain-injury","display_name":"brain injury","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2779554857","wikidata":"https://www.wikidata.org/wiki/Q335099","display_name":"Edaravone","level":2,"score":0.9883020520210266},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.9456990957260132},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.6442784070968628},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5570364594459534},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47582510113716125},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.44664838910102844},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.44600406289100647},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38417860865592957},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3700777590274811},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25480514764785767},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23794683814048767},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.1729346215724945},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13934993743896484}],"mesh":[{"descriptor_ui":"D000077553","descriptor_name":"Edaravone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077553","descriptor_name":"Edaravone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000983","descriptor_name":"Antipyrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000983","descriptor_name":"Antipyrine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001930","descriptor_name":"Brain Injuries","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016166","descriptor_name":"Free Radical Scavengers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016166","descriptor_name":"Free Radical Scavengers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019394","descriptor_name":"Ki-67 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.4103//ant.33-1_111_0067","doi":"https://doi.org/10.4103//ant.33-1_111_0067","is_oa":true,"landing_page_url":"https://doi.org/10.4103//ant.33-1_111_0067","pdf_url":null,"source":{"id":"https://openalex.org/S4306500427","display_name":"Acta Neurologica Taiwanica","issn_l":"1028-768X","issn":["1028-768X","3050-9173"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Taiwanica","raw_type":"journal-article"},{"id":"pmid:37848239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37848239","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Taiwanica","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b3a7875a3a9e4fefa71a3bd1162561eb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b3a7875a3a9e4fefa71a3bd1162561eb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Neurologica Taiwanica, Vol 33, Iss 1, Pp 9-12 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.4103//ant.33-1_111_0067","doi":"https://doi.org/10.4103//ant.33-1_111_0067","is_oa":true,"landing_page_url":"https://doi.org/10.4103//ant.33-1_111_0067","pdf_url":null,"source":{"id":"https://openalex.org/S4306500427","display_name":"Acta Neurologica Taiwanica","issn_l":"1028-768X","issn":["1028-768X","3050-9173"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Taiwanica","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1971793659","https://openalex.org/W1975609057","https://openalex.org/W1984384126","https://openalex.org/W1987676334","https://openalex.org/W1992112631","https://openalex.org/W2030422892","https://openalex.org/W2055364498","https://openalex.org/W2071568301","https://openalex.org/W2074487828","https://openalex.org/W2085493769","https://openalex.org/W2088435772","https://openalex.org/W2095763776","https://openalex.org/W2165633855","https://openalex.org/W2466516086","https://openalex.org/W2998575879","https://openalex.org/W4296483684"],"related_works":["https://openalex.org/W4220869992","https://openalex.org/W2481624906","https://openalex.org/W2367032476","https://openalex.org/W2358552317","https://openalex.org/W2156712776","https://openalex.org/W4293779041","https://openalex.org/W73885394","https://openalex.org/W3030388638","https://openalex.org/W2351506266","https://openalex.org/W2944303861"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"study":[2,214],"aims":[3],"to":[4,201],"investigate":[5],"the":[6,24,136,143,154,162,223],"effect":[7],"of":[8,212,227],"edaravone":[9,67,73,84,194,217],"in":[10,23,91,135,153,161,189,222],"preventing":[11],"cisplatin-induced":[12,128,228],"brain":[13,129,229],"damage.":[14,130],"METHODS:":[15],"Forty":[16],"female":[17],"Wistar":[18],"albino":[19],"rats":[20,93],"were":[21,28,39,85,103,139],"included":[22],"study.":[25],"4":[26,71],"groups":[27,145,164],"created.":[29],"In":[30,57],"group":[31,58,138,156,191,195],"1":[32,65,82],"(control":[33],"group)":[34,48,61,74],"(n=10),":[35,49,62,75],"neither":[36],"any":[37],"drugs":[38],"given":[40],"nor":[41],"anything":[42],"was":[43,55,68,89,115,157,173,182,187,199],"performed.":[44],"Group":[45,70],"2":[46],"(cisplatin":[47],"single":[50,63,76],"dose":[51,64,77],"7.5":[52,78],"mg/kg":[53,66,79,83],"cisplatin":[54,80,137,155,190],"given.":[56,86],"3":[59,95],"(edaravone":[60],"administered.":[69],"(cisplatin+":[72],"and":[81,108,122,132,179,196,225],"Brain":[87,113],"tissue":[88,102,114,151,185],"removed":[90],"all":[92],"after":[94],"days.":[96],"Blood":[97],"samples":[98],"taken":[99],"from":[100],"heart":[101],"examined":[104],"for":[105,117],"malondialdehyde":[106],"(MDA)":[107],"nitric":[109],"oxide":[110],"(NO)":[111],"levels.":[112],"evaluated":[116],"damage":[118,152,186],"with":[119],"p53,":[120,177],"GFAP":[121,178],"Ki":[123,180],"67.":[124],"RESULTS:":[125],"Edaravone":[126],"reduced":[127],"MDA":[131],"NO":[133],"levels":[134],"significantly":[140,158],"higher":[141,159,188],"than":[142,148,160,167,192,207],"other":[144,163],"(p":[146,165,205],"less":[147,166,206],"0.05).":[149,168,208],"Likewise,":[150],"The":[169,210],"immunohistochemical":[170],"staining":[171],"which":[172],"done":[174],"by":[175],"using":[176],"67":[181],"shown":[183],"that":[184,216],"cisplatin+":[193],"this":[197],"difference":[198],"found":[200],"be":[202,220],"statistically":[203],"significant":[204],"CONCLUSION:":[209],"findings":[211],"our":[213],"suggest":[215],"therapy":[218],"may":[219],"effective":[221],"prevention":[224],"treatment":[226],"injury.":[230]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-19T00:00:00"}